These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21659751)

  • 1. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis strategies in development.
    LaRosa SP; Opal SM
    Clin Chest Med; 2008 Dec; 29(4):735-47, x-xi. PubMed ID: 18954707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment.
    Cunneen J; Cartwright M
    AACN Clin Issues; 2004; 15(1):18-44. PubMed ID: 14767363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis: a roadmap for future research.
    Cohen J; Vincent JL; Adhikari NK; Machado FR; Angus DC; Calandra T; Jaton K; Giulieri S; Delaloye J; Opal S; Tracey K; van der Poll T; Pelfrene E
    Lancet Infect Dis; 2015 May; 15(5):581-614. PubMed ID: 25932591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toll-like receptors and their role in regulation of the inflammatory response in sepsis].
    Krawczyk-Michalak K; Glapiński A; Brzezińska-Błaszczyk E
    Anestezjol Intens Ter; 2008; 40(4):253-59. PubMed ID: 19517667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory mechanisms of sepsis.
    Shubin NJ; Monaghan SF; Ayala A
    Contrib Microbiol; 2011; 17():108-124. PubMed ID: 21659749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.
    Fry DE
    Am Surg; 2012 Jan; 78(1):1-8. PubMed ID: 22273282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-modulating interventions in critically ill septic patients: pharmacological options.
    Toft P; Tønnesen E
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):491-501. PubMed ID: 22114858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitions and pathophysiology of sepsis.
    Sagy M; Al-Qaqaa Y; Kim P
    Curr Probl Pediatr Adolesc Health Care; 2013; 43(10):260-3. PubMed ID: 24295606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock.
    Wheatley C
    Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pro-and anti-inflammatory host responses.
    van der Poll T; van Zoelen MAD; Wiersinga WJ
    Contrib Microbiol; 2011; 17():125-136. PubMed ID: 21659750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis.
    Huttunen R; Aittoniemi J
    J Infect; 2011 Dec; 63(6):407-19. PubMed ID: 21840338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.